Antiviral and antioxidant activity of a hydroalcoholic extract from Humulus lupulus L. by DI SOTTO, Antonella et al.
Research Article
Antiviral and Antioxidant Activity of a Hydroalcoholic
Extract from Humulus lupulus L.
Antonella Di Sotto ,1 Paola Checconi ,2,3 Ignacio Celestino,2,3 Marcello Locatelli,4
Stefania Carissimi,5Marta De Angelis,2Valeria Rossi,2Dolores Limongi,3 Chiara Toniolo ,6
Lucia Martinoli,1 Silvia Di Giacomo,1 Anna Teresa Palamara ,2,3 and Lucia Nencioni 2
1Department of Physiology and Pharmacology V. Erspamer, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy
2Department of Public Health and Infectious Diseases, Laboratory Affiliated to Istituto Pasteur Italia-Fondazione Cenci Bolognetti,
Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy
3IRCCS San Raffaele Pisana, Department of Human Sciences and Promotion of the Quality of Life, San Raffaele Roma Open
University, Via di Val Cannuta 247, 00166 Rome, Italy
4Department of Pharmacy, University “G. D’Annunzio” of Chieti-Pescara, Via dei Vestini 31, 66100 Chieti, Italy
5Department of Biochemical Sciences “A. Rossi Fanelli”, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy
6Department of Environmental Biology, Sapienza University of Rome, P.le Aldo Moro 5, 00185 Rome, Italy
Correspondence should be addressed to Antonella Di Sotto; antonella.disotto@uniroma1.it
and Paola Checconi; paola.checconi@uniroma1.it
Received 10 January 2018; Accepted 16 May 2018; Published 24 July 2018
Academic Editor: Ralf Hausmann
Copyright © 2018 Antonella Di Sotto et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is
properly cited.
A hydroalcoholic extract from female inflorescences of Humulus lupulus L. (HOP extract) was evaluated for its anti-influenza
activity. The ability of the extract to interfere with different phases of viral replication was assessed, as well as its effect on the
intracellular redox state, being unbalanced versus the oxidative state in infected cells. The radical scavenging power, inhibition
of lipoperoxidation, and ferric reducing activity were assayed as antioxidant mechanisms. A phytochemical characterization of
the extract was also performed. We found that HOP extract significantly inhibited replication of various viral strains, at different
time from infection. Viral replication was partly inhibited when virus was incubated with extract before infection, suggesting a
direct effect on the virions. Since HOP extract was able to restore the reducing conditions of infected cells, by increasing
glutathione content, its antiviral activity might be also due to an interference with redox-sensitive pathways required for viral
replication. Accordingly, the extract exerted radical scavenging and reducing effects and inhibited lipoperoxidation and the
tBOOH-induced cytotoxicity. At phytochemical analysis, different phenolics were identified, which altogether might contribute
to HOP antiviral effect. In conclusion, our results highlighted anti-influenza and antioxidant properties of HOP extract, which
encourage further in vivo studies to evaluate its possible application.
1. Introduction
Nowadays, influenza remains one of the main causes of mor-
bidity worldwide, with seasonal epidemics and periodic pan-
demics. The disease is caused by an enveloped, RNA virus,
which infects mainly the upper airways, but complications
at lower respiratory tract can occur, especially in children
and elderly [1].
Although different strategies have been approached to
prevent the disease and/or manage its complications, the only
anti-influenza drugs approved byFDAbelong to two classes of
inhibitors, which target the viral matrix protein 2 and neur-
aminidase [2]. Unfortunately, their efficacy is often limited
by toxicity and by the emergence of novel drug-resistant viral
mutants, thus requiring alternative and more effective thera-
peutic strategies [3]. Research in the field is looking for
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alternativemolecules, both of natural and synthesis origin that
could interfere with different targets, including cell host
structures and pathways that virus exploits for its replica-
tion, and reduce the probability of drug resistance [4–6].
Several intracellular pathways that influenza virus acti-
vates are redox-sensitive [7, 8], and interestingly, some anti-
oxidant molecules, including polyphenols, that are able to
modulate the intracellular redox balance, also show anti-
influenza activity [9–11]. Natural polyphenolic compounds,
proanthocyanidins and catechins, have been found to possess
antiviral properties, particularly against influenza A [12–14].
Female strobilus inflorescences (hops or cones) of
Humulus lupulus L. (Fam. Cannabaceae) are widely used in
the brewing industry as preservative and flavouring additives;
in fact, H. lupulus is considered as an essential ingredient in
beer, contributing to the bitter flavour and the characteristic
hoppy aroma and providing preservative and antimicrobial
effects [15–18]. Beer is often considered to be a “functional
beverage” as a source of health-promoting substances [19].
Among them, polyphenolic compounds, mainly prenylflavo-
noids and procyanidins, along with chalcones (namely,
xanthohumol) and the phytoestrogen 8-prenylnaringenin,
have gained the most attention [17, 20]. Furthermore, H.
lupulus extracts are used in traditional medicine as bitter sto-
machic and as remedies for mild sleeping disorders, in com-
bination with other sedative herbs such as valerian, passion
flower, and lemon balm [21].
H. lupulus and its polyphenolic constituents are reported
to possess other interesting biological properties, including
antimicrobial, antioxidant, anti-inflammatory, and chemo-
preventive activities [22–24]. Although antimicrobial (anti-
bacterial and antifungal) properties are well known, little is
reported about the antiviral activity of crude hop extracts
and their purified components. Buckwold et al. [25] found
that iso-α-acids and xanthohumol have a moderate antiviral
activity against different RNA and DNA viruses, thus sug-
gesting their possible role as lead compounds for more active
antiviral agents.
In line with this evidence and our preliminary results
[26], in the present study, the anti-influenza activity of a
hydroalcoholic extract from the female inflorescences of H.
lupulus (HOP extract) was evaluated. The ability of HOP to
interfere with specific steps of viral replication was shown
using an in vitro model, represented by permissive epithelial
cell lines infected with different influenza A virus strains.
The HOP extract was characterized for its phenolic
composition by both high-performance thin-layer chroma-
tography (HPTLC) and high-performance liquid chroma-
tography (HPLC-PDA), and the total polyphenol, tannin,
and flavonoid amount was determined colorimetrically.
Finally, the radical scavenger ability, the crocin bleaching
activity, the inhibition of lipoperoxidation, and the iron
reducing activity were evaluated as possible antioxidant
and cytoprotective mechanisms of the HOP extract.
2. Materials and Methods
2.1. HOP Extract. A hydroalcoholic extract from the female
inflorescences of H. lupulus L. (HOP extract; batch n.
1101385; code n. 3120004; ratio drug/extract 4 : 1), kindly
supplied by EPO S.r.l. (Milan, Italy), was used to perform
the experiments. The extract was standardized to contain
0.4% of flavonoids, determined as rutin equivalents.
2.2. Chemicals. All the chemicals, including 3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT; 98%
purity), tert-butyl hydroperoxide (tBOOH, 70% wt in
H2O), Triton X-100, 1,1-diphenyl-2-picryl-hydrazyl (DPPH;
95% purity), 2,2′-azino-bis(3-thylbenzothiazoline-6-sulfonic
acid) diammonium salt (ABTS; 98% purity), 2,2′-azobis (2-
methylpropionamidine) dihydrochloride (AAPH; 97%
purity), ferrozine (97% purity), hydroxylamine hydrochlo-
ride (98% purity), iron(III) chloride (FeCl3 × 6H2O; 97%
purity), iron(II) sulfate heptahydrate (FeSO4 × 7H2O; 99%
purity), potassium hexacyanoferrate(III) (99.9% purity), iro-
n(II) chloride (FeCl2 × 4H2O; 99% purity), Trolox (97%
purity), standard phenolic compounds (>95% purity), the
solvents ethanol (EtOH; 99.5% purity) and methanol
(MeOH; 99.5% purity), and antiactin antibody were obtained
from Sigma-Aldrich Co. (St. Louis, MO, USA). Sodium car-
bonate (Na2CO3; 99.999% purity), Folin-Ciocalteu’s phenol
reagent, tannic acid (Ph Eur purity), and aluminium chloride
hexahydrate (AlCl3 × 6H2O; Ph Eur purity) were purchased
from Merck (Darmstadt, Germany). Furthermore, the
reagents for antiviral studies, if not otherwise specified, were
purchased from Invitrogen (Carlsbad, CA, USA).
2.3. Phytochemical Analysis
2.3.1. Chromatographic Analysis. HPTLC and HPLC-PDA
phenolic pattern were evaluated according to previous stan-
dardized methods [27]. To perform the HPTLC analysis,
the extract and the selected standard polyphenols rutin,
chlorogenic acid, catechin, and gallic acid were dissolved in
methanol at concentration of 30mg/ml and 1mg/ml, respec-
tively. The phenolics were identified by comparison with the
selected standards (Rf values, colors, and UV spectra).
For the HPLC-PDA, the HOP extract (20μl) was dis-
solved in the mobile phase (1 : 10 dilution factor) and injected
into HPLC-PDA system. The standard phenolics, including
benzoic acid, carvacrol, catechin, chlorogenic acid, epicate-
chin, gallic acid, harpagoside, naringenin, naringin, p-OH
benzoic acid, quercetin, rutin, sinapinic acid, syringic acid,
t-cinnamic acid, t-ferulic acid, and vanillic acid, were
enclosed in the analysis.
2.3.2. Total Polyphenols, Tannins, and Flavonoids. The total
polyphenol, tannin, and flavonoid content was determined
according to standardized spectrophotometric methods, with
minor changes [27]. The total amount of both polyphenols
and tannins was calculated as tannic acid equivalents
(TAE), while flavonoids were expressed as quercetin equiva-
lents (QE).
2.4. Antiviral Activity
2.4.1. Cell Cultures. MDCK (Madin-Darby canine kidney)
cells and A549 human lung carcinoma cells were grown in
RPMI 1640 and DMEMmedium, respectively, supplemented
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with 10% fetal bovine serum (FBS), 0.3mg/ml glutamine,
100U/ml penicillin, and 100μg/ml streptomycin.
2.4.2. Cytotoxicity Assay. The cytotoxicity of the treatments
was evaluated by using the 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide reduction assay [28]. The
HOP extract was dissolved in DMSO (concentrations range
20–180μg/ml) and added to both MDCK and A549 cells
for 24 h. The cytotoxicity was calculated as percentage reduc-
tion in viability of HOP-treated cells compared to control,
that is, cells treated with DMSO alone.
In the cytoprotection assay, after a 24 h pretreatment
with the HOP extract, a low-toxic concentration (about 40%
cytotoxicity as found in preliminary experiments) of the
prooxidant agent tBOOH (5μM) was added for 2 h to cells,
and then the cell viability was measured as described above.
2.4.3. Viral Infection, Titration, and Viral mRNA
Quantification. Confluent monolayers of MDCK or A549
cells were challenged with the following influenza A virus
strains: human A/Puerto Rico/8/34 H1N1 (PR8), A/NWS/
33 H1N1 (NWS), and pandemic A/California/04/09 H1N1
(pH1N1) strains or avian Parrot/Ulster/73 H7N1 (ULSTER)
strain, at a multiplicity of infection (m.o.i.) of 3 (high m.o.i.)
and 0.3 (low m.o.i.) for 1 h at 37°C. After the viral adsorption,
the cells were washed with phosphate-buffered saline (PBS)
and then incubated with medium supplemented with 2%
FBS for 24 or 48 h.
For the evaluation of the antiviral activity, HOP extract
was dissolved in DMSO and then diluted to the final con-
centrations in the cell culture medium. The highest DMSO
concentration present in the culture medium was 0.2%.
Control cells were treated with DMSO alone at the same
concentration.
Treatment with HOP was performed as follows: 1 h
before the infection (b.i.), during the 1 h adsorption period
(d.i.), and after the adsorption (postinfection, p.i.) or before,
during, and after the infection (b.d.p.i.).
To evaluate the virucidal effect, HOP extract was incu-
bated directly with the virus for 1 h at 37°C. Then, the mix-
ture was used to infect the cell culture as described above.
Virus production was determined in the supernatants of
infected cells 24 and 48 h p.i., by measuring the hemaggluti-
nating units (HAU) or the tissue culture infectious dose 50
(TCID50), as previously described [29].
For M1 mRNA quantification, total RNA was isolated
from A549 cell lysates (Total RNA Purification Plus Kit, Nor-
gen Biotek, Thorold, ON, Canada) and used as a template for
generating cDNA (iScript cDNA Synthesis Kit, Bio-Rad,
Milan, Italy). An aliquot of the cDNA was subjected to 40
cycles of RT-PCR amplification (95°C, 10 sec; 60°C, 30 sec)
using iQ SYBR Green Supermix and a LightCycler iQ 5
(Bio-Rad, Milan, Italy). The housekeeping gene ribosomal
protein L13A (Rpl13a) was used for normalization. Relative
quantitative evaluation was performed by the comparative
ΔΔCt method.
2.4.4. Immunoblotting Analysis. Influenza virus-infected and
HOP-treated (as described above) MDCK or A549 cells were
lysed and analyzed by SDS-PAGE followed by Western
blotting with anti-influenza (Merck Millipore, Darmstadt,
Germany) and antiactin antibodies. HRP-linked anti-goat
and anti-mouse (Jackson ImmunoResearch, Newmarket,
UK) were used as secondary antibodies. The membranes
were developed using Clarity Western ECL substrate
(Bio-Rad, Hercules, CA, USA).
2.4.5. Immunofluorescence Analysis. Following incubation of
PR8 virus with HOP extract and infection with the mixture
(or with PR8 alone), A549 cells were fixed with methanol,
permeabilized with 0.1% Triton X-100 and stained with
anti-NP antibody (Bio-Rad, Hercules, CA, USA). Alexa-
Flour 488-conjugated anti-mouse was used as secondary
antibody. Nuclei were stained with 4′,6-diamidino-2-
phenylindole (DAPI).
2.4.6. Glutathione Assay. GSH level was quantified in A549
cell lysates from PR8- or pH1N1-infected and HOP-treated
(p.i. and b.d.p.i.) cells, as previously described [30]. The
GSH levels were also measured in the lysates from cells
treated with the prooxidant agent tBOOH (5μM). In these
experiments, the antioxidant effect of the HOP extract was
evaluated under pretreatment and cotreatment plus post-
treatment protocols. Protein content was determined with
Bradford reagent (Bio-Rad, Hercules, CA, USA) and GSH
level expressed as nmol/mg proteins.
2.5. Antioxidant Activity. All tests were performed in 96-
multiwell microplates away from direct light; the experiments
were repeated at least twice, and in each experiment, each
concentration was tested in triplicate. Data obtained from at
least two experiments were pooled for statistical analysis.
To perform the assays, the HOP extract was dissolved in
deionized water, and in each test, the suitable negative or pos-
itive controls (Trolox, rutin, and quercetin used as standard
antioxidant agents) were included. The absorbance was mea-
sured by a microplate reader (Epoch Microplate Spectropho-
tometer, BioTek).
2.5.1. Radical Scavenging Activity. DPPH and ABTS radical
scavenging activities were determined according to Di Sotto
et al. [27] with minor changes. Briefly, a DPPH solution
(40μl; 0.1mM in EtOH 100% v/v) and the test sample
(160μl) were incubated for 30 minutes in the dark at room
temperature, and then the absorbance of DPPH radical was
measured at 517 nm. For the ABTS assay, equal volumes of
ABTS (5mM in PBS 0.1M, pH7.0) and AAPH (2mM in
PBS 0.1M, pH7.0) were mixed and incubated for 45 minutes
at 68°C, to obtain the ABTS radical cation. The sample (20μl)
was added to the radical solution (180 μl), and the plates were
incubated for 10 minutes in the dark at 37°C and then read at
734 nm. The percentage of scavenger activity was calculated
as follows: 100 × Acontrol − Asample /Acontrol , where Acontrol is
the absorbance of the radical alone, while Asample is that of
radical with sample.
2.5.2. Crocin Bleaching Assay. The assay was carried out
according to Di Majo et al. [31] with minor changes. To per-
form the assay, a crocin solution (40μl; 3.5mM in PBS 0.1M,
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pH7.4), AAPH (10μl; 0.25M in PBS 0.1M, pH7.4), the
extract (40μl), and PBS (110μl; 0.1M, pH7.4) were mixed;
then the mixture was incubated at 40°C in the dark for 60
minutes. After incubation, the crocin absorbance was read
at 443nm. The percentage of antioxidant activity was calcu-
lated as follows: 100 × Acontrol − Asample /Acontrol , where
Acontrol is the absorbance of the crocin alone, while Asample
is that of radical with sample.
2.5.3. Inhibition of Lipid Peroxidation. The assay was carried
out by the ferric thiocyanate method according to Di Sotto
et al. [32]. Briefly, the sample (125μl), PBS (500μl; 0.2M,
pH7.0), and a linoleic emulsion (625μl) were incubated at
37°C for 96h. Some aliquots (100μl) were taken every 24 h
and further added with ethanol (470μl; 75% v/v), FeCl2
(10μl; 200mM in 3.5% w/vHCl), and potassium hexacyano-
ferrate (KSCN, 10μl; 30% w/v in deionized water). Perox-
ides, released during linoleic acid peroxidation, oxidize
ferrous to ferric ions, so forming a red ferric(III) thiocyanate
complex, measured at 500nm spectrophotometrically. The
percentage of lipoperoxidation inhibition (LPI) was calcu-
lated as follows: 1 – Asample/Acontrol × 100, where Acontrol
was the absorbance of the vehicle while Asample is that of
the tested sample.
2.5.4. Ferric Reducing Activity. The activity was evaluated by
the ferrozine assay, according to previous published methods
[27]. Briefly, equal volumes of FeCl3× 6H2O (200μM in ace-
tate buffer solution 0.1M, pH4.5) and the samples were
mixed for 2 minutes, and then a ferrozine solution (5mM in
acetate buffer solution 0.1M, pH4.5) was added to the mix-
ture. The ferrous ion-ferrozine complex, corresponding to
the reducing activity of the sample, was measured at 562nm
and the percentage of activity was calculated as follows:
100 × Acontrol − Asample /Acontrol, where Acontrol is the absor-
bance of the vehicle, while Asample is that of the tested sample.
2.6. Statistical Analysis. For the antioxidant studies, all
values are expressed as mean± SE and n represents the
number of experiences.
For the antiviral studies, all values are expressed as
mean± SD and n represents the number of replicates for
each treatment.
Statistical analysis was performed by GraphPad
Prism™ software (GraphPad Software Inc., San Diego,
California, USA).
The one-way analysis of variance (one-way ANOVA),
followed by Dunnett’s multiple comparison posttest, was
used to analyze the difference among different treatments,
while the Student’s t-test was applied to determine the statis-
tical significance between two different experimental condi-
tions. The values of P < 0 05 were considered significant.
The concentration-response curves were constructed
using the “Hill equation”: E = E max/ 1 + 1050LogEC/A
HillSlope ,
where E is the effect expressed as increase in the ferrous
chelation at a given concentration of agonist, E max is the
maximum ferrous chelating activity, IC50 is the concentra-
tion that produces a 50% of the inhibitory response, A is
the agonist concentration in molar, and HillSlope is the slope
of the agonist curve.
3. Results and Discussion
3.1. Phytochemical Analysis. The HPTLC analysis showed the
presence in the chromatogram of different polyphenols, evi-
denced as fluorescent spots, and better visualized by derivatiza-
tion with NPR and anisaldehyde (Figure S1). Among them,
rutin, chlorogenic acid, and gallic acid were identified. The
HPLC-PAD analysis confirmed the presence of rutin as one
of the most abundant phenolic compounds, along with
syringic acid and ferulic acid; lower levels were highlighted for
p-OH benzoic acid, gallic acid, and chlorogenic acid (Table 1).
Colorimetric determinations highlighted a polyphenols/
tannins ratio of about 4, while the flavonoid content agreed
with that declared by the supplier (Table 2). On the
basis of the DER, the total flavonoid content of the HOP
extract resulted to be about 0.4% of the raw material.
According to Peterson and Dwyer [33], which classified the
flavonoid concentration in foods as low (0.1–39.9mg/kg),
Table 1: Phenolic composition of the HOP extract by HPLC-PDA
analysis.
Compounds
Concentration (μg/mg of the sample)
(mean± SD)
Benzoic acid nd
Carvacrol nd
Catechin nd
Chlorogenic acid 0.017± 0.001
t-Cinnamic acid nd
Epicatechin nd
t-Ferulic acid 0.078± 0.005
Gallic acid 0.026± 0.002
Harpagoside nd
Naringenin nd
Naringin nd
p-OH benzoic acid 0.029± 0.002
Quercetin nd
Rutin 0.363± 0.001
Sinapinic acid nd
Syringic acid 0.289± 0.020
Vanillic acid BLD
BLD: below limit of detection; nd: not detected.
Table 2: Amounts of total polyphenols, tannins, and flavonoids in
the HOP extract (n = 3).
Compound
HOP extract (μg/mg of the sample)
(mean± SE)
Total polyphenols (TA
equivalents)
7.1± 0.35
Tannins (TA equivalents) 1.7± 0.06
Flavonoids (Q equivalents) 3.8± 0.59
TA: tannic acid; Q: quercetin.
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moderate (40–99.9mg/kg), and high (>100mg/kg), the
raw material resulted to contain a high flavonoid (i.e.,
950mg/kg) amount, thus suggesting its possible role as
a nutraceutical source.
According to our results, Inui et al. [24] highlighted
that syringic acid, along with procyanidins and catechins,
was the major constituent of a hydroacetone extract from
the H. lupulus plant, with lower levels of quercetin, narin-
genin, kaempferol, and xanthohumol. Ferulic acid was also
found in a methanolic extract from cones of H. lupulus
[34]. Furthermore, quercetin glycosides, such as rutin, iso-
quercitrin, and isoquercitrin malonate, have been identi-
fied as the main bioactive constituents of the water
extract from hop plant [35]. Quercetin and kaempferol
glycosides were also found in H. lupulus cones and young
shoots [36, 37].
Our sample of HOP extract did not contain querce-
tin and naringenin, in spite of a high amount of rutin.
This could be a consequence of the mild extraction con-
dition (based on a maceration in ethanol 90% v/v),
which allows a poor hydrolysis of the glycoside. In fact,
the rutin hydrolysis has been found to occur under acid-
ified conditions with high concentrated hydrochloric acid
and extended heating times [38]. A significant influence
of the extraction method on the phenolic concentration
in H. lupulus extracts was reported: in spite of a very
low phenolic amount in the aqueous extracts, the hydro-
alcoholic samples were found richer in epicatechin,
chlorogenic acid, gallic acid, catechin, benzoic acid, feru-
lic acid, and o-coumaric acid [39]. The extraction method
also affects the total amount of prenylflavonoids and bit-
ter, being poorly stable under prolonged and hot extrac-
tion conditions [40].
3.2. Antiviral Activity
3.2.1. HOP Extract Inhibits Influenza A Virus Replication in
Different Phases of the Virus Life Cycle. In order to study a
possible antiviral activity of the HOP extract, first of all it
has been necessary to rule out any cytotoxic effect in the
tested cell lines. Using concentrations of the extract from 20
to 180μg/ml on MDCK and A549 epithelial cell lines, we
demonstrated that the percentage of cellular viability was
equal or higher than 90% compared to control cells till the
concentration of 140μg/ml in both cell lines (Figure 1(a)).
Since a slight reduction (about 13%) in cell proliferation
was observed when cells were treated with HOP 180μg/ml,
we chose to exclude this concentration for the following
experiments.
Next, we tested the antiviral activity of different concen-
trations (10–140μg/ml) of HOP on kidney epithelial MDCK
cells, well known to be highly permissive to influenza virus.
As shown in Figure 1(b), the extract inhibited PR8 viral rep-
lication in a statistically significant (∗P < 0 05 starting from
50μg/ml) and concentration-dependent manner, with an
IC50 value of 99 (confidential limits 93–110) μg/ml. Western
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Figure 1: (a) Cell viability (percentage of control) of MDCK and A549 cells treated with different concentrations of HOP extract for 24 h as
evaluated by MTT assay. (b) Percentage of inhibition of viral titer induced by HOP extract (10–140 μg/ml) on MDCK cells infected with PR8
virus (low m.o.i.) and treated with HOP after infection for 24 h. Data are mean ± SD from three independent biological replicates, each one
performed in two technical replicates (n = 3). ∗P < 0 05 versus untreated infected cells by Student’s t-test. (c) Western blot analysis of viral
proteins (HA: hemagglutinin; NP: nucleoprotein; NA: neuraminidase; M1: matrix 1 protein) from PR8-infected MDCK cells, treated with
HOP (80–140 μg/ml) after infection for 24 h.
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blot analysis of viral proteins similarly showed a dose-
dependent reduction of hemagglutinin (HA), neuraminidase
(NA), nucleoprotein (NP), and matrix protein1 (M1) in
infected and HOP-treated cells compared to the infected
ones (Figure 1(c)).
On the basis of this preliminary evidence, the highest
concentration of 140μg/ml was chosen for the antiviral
assays in the human lung epithelial A549 cells. Particularly,
these cells were infected with different strains of influenza
A virus (PR8, pH1N1, NWS, and ULSTER) and treated with
HOP at different times from the infection: before (b.i.), dur-
ing (d.i.), and after (p.i.) or before, during, and after the infec-
tion (b.d.p.i). As shown in the charts of Figure 2, the
treatment before the infection was ineffective. Instead, when
the HOP extract was added to the culture medium with the
virus during the 1 h infection, it was able to reduce viral titer,
in a partial but significant degree for PR8, NWS, and
ULSTER strains (46%, 50%, and 29% of inhibition, resp.).
The HOP treatment performed after the infection signifi-
cantly reduced pH1N1, PR8, and ULSTER titer (75%, 44%,
and 29%, resp.). Interestingly, when the treatment was per-
formed before, during, and after the infection, it significantly
reduced viral titer of all the strains, suggesting an inhibitory
additive effect of the HOP extract, when it was continuously
present during all the time of infection.
3.2.2. HOP Extract Exerts a Partial Virucidal Effect. In the
attempt of explaining the molecular mechanism exerted by
the HOP extract on influenza virus-infected cells, we decided
to evaluate different steps of virus life cycle. First, we analyzed
the effect of HOP extract during the 1 h infection. For this
step, we could hypothesize a virucidal effect of the extract
or an effect on an early phase of the viral life cycle. HOP
extract was incubated directly with the virus and then the
mixture used to infect the cells, as described in Materials
and Methods. PR8 production, measured by the hemaggluti-
nating assay, was significantly inhibited, both when high and
low m.o.i. of virus were used, but with a higher percentage of
inhibition when low m.o.i. was used (about 70% and almost
92% of inhibition, resp., Figure 3(a)). Results were confirmed
by using the TCID50 assay, that is, the inhibition in viral rep-
lication was 80% when the extract was incubated with high
m.o.i. of virus and over 90% when low m.o.i. of virus was
used, confirming an inhibitory effect of the HOP extract that
was viral dose-dependent, as it would be for a virucidal effect
(Table 3). Western blot analysis of PR8 proteins obtained
from lysates of cells infected with PR8-HOP mixture showed
a lower expression of viral proteins compared to those in cells
infected with the virus alone (Figure 3(b)). Similar results were
obtained when cells were infected with other viral strains pre-
incubated with HOP extract (see Figure S2). Furthermore, in
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Figure 2: Viral titer measured in supernatants of A549 cells infected with different influenza A virus strains and treated with 140 μg/ml HOP
extract 1 h before the infection (b.i.), during the 1 h adsorption period (d.i.), and after the adsorption (postinfection: p.i.) or before, during, and
after the infection (b.d.p.i.). Viral production was determined 24 h p.i. by hemagglutinating assay and expressed as percentage of HAU, (where
titer from the untreated, infected cells was considered 100%). Data are mean ± SD from three independent biological replicates, each one
performed in two technical replicates (n = 3). ∗P < 0 05 versus untreated infected cells by Student’s t-test.
6 Oxidative Medicine and Cellular Longevity
these conditions, an immunofluorescence analysis of the viral
nucleoprotein (NP) was performed using low m.o.i. of virus.
According with Western blot results, the images in Figure 4
showed that NP was less expressed in cells infected with the
virus-HOP mixture compared to the infected ones.
Collectively, these results indicate that the HOP extract exerts
at least a partial direct effect on viral particles, reducing their
infectious ability. It has been already shown that the extract
exerts an injurious effect on bacterial cell structures; in
particular, its hydrophobic components are incorporated into
the cell membranes, altering ion exchange [23]. Therefore, it
is plausible that HOP components could be incorporated in
the membrane of enveloped viruses, as influenza, destabilizing
viral structure. However, we cannot exclude that HOP could
enter the cells and act in an early phase of the cycle. Looking
at the immunofluorescence images, the localization of NP
appeared also affected, being in the nuclei of the HOP-treated
infected cells, while it was diffused throughout the cell (nuclei
plus cytoplasm) in untreated infected cells (Figure 4). This
result suggests that the HOP components could also enter the
cell and act by interfering with virus-activated cellular
pathways, that in turn control NP traffic and localization.
To deep inside the mechanisms hypothesized, we per-
formed a second set of experiments during the first replica-
tion cycle of the virus. First of all, we repeated an
immunofluorescence analysis of viral NP using high m.o.i.
of virus for 4 h and 8h of infection. As shown in
Figure 5(a), left panel, NP was localized both in the nuclei
and the cytoplasm of infected cells with an increased inten-
sity from 4h p.i. to 8 h p.i., accordingly with the progression
of the viral life cycle. When the virus was preincubated with
HOP (middle panel), the pictures appeared different, as a
weak, diffused staining was visible with some brighter spot
at 4 h p.i., which could represent viral particles sticking to
the cell membranes and a lower number of infected cells at
8 h p.i. Moreover, in the cells that were infected, NP was
localized mainly in the nuclei. When the cells were infected
and treated with HOP after infection (right panel), the main
effect was a different NP localization, being the viral protein
mainly in the nuclei of infected cells at 8 h p.i.
qRT-PCR of mRNA levels of viral M1 performed at 2 h
p.i. (Figure 5(b)) revealed a decrease in the expression of
M1 mRNA in cells infected and HOP treated with different
procedures, but especially with virus-HOP mixture, that
could be the result of the reduced number of cells being
infected. Accordingly, TCID50 from supernatants of infected
cells 8 h p.i. showed higher inhibition when cells have been
infected with virus-HOP mixture (Figure 5(c)).
3.2.3. HOP Extract Restores the Intracellular GSH Levels of
Influenza Virus-Infected Cells. In the present study, we also
observed that HOP extract exerts an antiviral effect when
added after the infection and especially before, during, and
after the infection. These data let us to hypothesize that
HOP could act also in another step of virus life cycle, with
a further mechanism, that is, interfering with the redox
imbalance caused by influenza virus. It is well known in fact
that on the one hand, other H. lupulus extracts and some
polyphenols exhibited antioxidant properties [23]; on the
other hand, several viruses, including influenza, induce an
oxidative stress to activate redox-sensitive pathways useful
Table 3: TCID50 from supernatants of A549 cells infected with PR8
virus following incubation of the virus with 140μg/ml HOP.
Viral titer TCID50/ml I high m.o.i. I +HOP high m.o.i.
24 h 1585 316
48 h 3162 631
I low m.o.i. I +HOP low m.o.i.
24 h ND ND
48 h 35481 3162
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Figure 3: (a) Viral titer measured in supernatants of A549 cells infected with PR8 virus (high or low m.o.i.), following incubation of the virus
with 140μg/ml HOP extract. Titer was determined 24 h p.i. by hemagglutinating assay and expressed as percentage of HAU compared to that
from cells infected with untreated virus. Data are mean ± SD from three independent biological replicates, each one performed in two
technical replicates (n = 3). ∗P < 0 05 and ∗∗P < 0 01 versus untreated infected cells by Student’s t-test. (b) Western blot analysis of viral
proteins from samples obtained as described in (a). Actin was used as loading control.
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for their replication [8, 41] and a marker of redox changes
is represented by glutathione (GSH) depletion in infected
cells [29, 42]. Therefore, we measured the GSH levels in
infected cells and HOP-treated after or before, during,
and after the infection. Results were compared to infected
and uninfected cells (control, CTR). As we expected, viral
infection caused a significant GSH depletion (Figure 6).
Interestingly, treatment with the HOP extract after the infec-
tion was able to restore GSH levels of about 30% and 40% (in
PR8- and pH1N1-infected cells, compared to control). A
more significant antioxidant effect was found when HOP
extract was added before, during, and after the infection,
and indeed, the GSH content reached 60% (in pH1N1-
infected cells) and 73% (in PR8-infected ones) of that
measured in control cells.
In the attempt to explain if the higher GSH content upon
HOP treatment could be due to a reduced virus infection or a
regulatory effect of the extract, the A549 cells were treated for
2 h with the prooxidant agent tBOOH after a 24 h pretreat-
ment with the HOP extract. In these experimental condi-
tions, tBOOH induced a slight but significant reduction of
cell viability (about 20% lower than the vehicle) which disap-
peared in the presence of HOP (Figure S3a). These data were
also confirmed in Caco-2 cells (Figure S3b), which represent
a widely standardized model for studying oxidative stress-
induced toxicity and the effect of dietary antioxidants [43].
Also, the GSH levels were markedly reduced by tBOOH
(at least 70% reduction respect to the vehicle in all the
experimental conditions), as confirmed by the cell
morphology changes (Figures S4 and S5). Adding the HOP
extract to cells, both under pretreatment and cotreatment
plus posttreatment protocols, was able to partly counteract
the tBOOH-induced oxidative toxicity and the cell
morphology change (Figures S4 and S5). This evidence
confirms our hypothesis about the antioxidant power of the
tested sample, although the higher GSH levels found in the
PR8-infected cells with respect to those damaged by
tBOOH suggest that combined virucidal and antioxidant
mechanisms can contribute to the antiviral properties of the
HOP extract. Overall, the results indicate that HOP extract
actually acts as antioxidant into infected cells. It could
buffer reactive oxygen species (ROS), which are produced
during infection [44], and in this way, it could reduce GSH
depletion. This event in turn could block some redox-
regulated cell pathways important for influenza virus
replication. A lot of polyphenols have been shown able to
inhibit for example phosphorylation of MAP kinases,
including p38 MAPK and ERK, that are involved in the NP
traffic [4, 9, 45]. Further studies are needed to distinguish
the molecular pathways involved in the HOP extract
antiviral effect.
3.3. Antioxidant Activity. During influenza virus infection,
the NADPH oxidase isoform 4 (NOX4) is the main source
of ROS production [8]. Indeed, inhibition of NOX4 activ-
ity or RNA silencing for this enzyme, by blocking ROS
increase, prevents MAPK phosphorylation and inhibits
NP traffic and viral release. In order to clarify the possible
mechanisms by which the HOP extract exerted antioxidant
effects in the influenza virus-infected cells, different
in vitro antioxidant assays were performed. The radical
scavenging properties of the sample, based on hydrogen
and electron transfer, were evaluated against the synthetic
chromogenic DPPH and ABTS radicals. Particularly, the
HOP extract (0.001–2mg/ml) inhibited, in a significant and
concentration-dependent manner, both DPPH and ABTS
radicals, as confirmed by the IC50 values (Table 4). The pos-
itive control Trolox was about 115- and 150-fold more effec-
tive against DPPH and ABTS, respectively. According to the
Pearson analysis, these activities were significantly correlated
(Table 5), although the sample was most potent (almost two-
fold) against ABTS, likely suggesting a major involvement of
the electronic transfer in the scavenger activity. Taking into
account that DPPH and ABTS radicals strongly differ for
I
I + HOP
DAPI NP
(a)
(b)
Figure 4: Immunofluorescence images of viral nucleoprotein (green fluorescence) in A549 cells infected for 24 h with PR8 virus (a) and
following incubation of the virus with 140μg/ml HOP (b). Nuclei were stained with DAPI (blue).
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Figure 6: GSH levels measured in A549 cell lysates infected with PR8 or pH1N1 virus and treated with 140μg/ml HOP extract after the
adsorption (postinfection: p.i.) or before, during, and after the infection (b.d.p.i.). Levels are expressed as percentage of nmol/mg proteins
(where levels from control cells were considered 100%). Data are mean ± SD from three independent biological replicates (n = 3). ∗P < 0 05
and ∗∗P < 0 01 versus infected cells by Student’s t-test.
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Figure 5: (a) Immunofluorescence images of viral nucleoprotein (green fluorescence) in A549 cells infected for 4 h and 8 h with PR8 virus
(left panel), with PR8 and 140 μg/ml HOP mixture (middle panel) or HOP treated after PR8 infection (right panel). HAU/ml values (8 h
p.i.) are reported below the images. (b) M1 mRNA levels measured by qRT-PCR in A549 cells infected with PR8 virus for 2 h, with PR8/
HOP mixture or HOP treated during (d.i.), after (p.i.), or during plus after (d.p.i.) infection. (c) TCID50 from supernatants harvested 8 h
p.i. of same samples as in (a).
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chemical structures, affinities, and kinetics of reaction, a
higher affinity of the HOP constituents for ABTS can be
hypothesized. A hydroalcoholic extract from H. lupulus
cones exhibited radical scavenging effects of DPPH radical
at higher concentrations with respect to hexane and metha-
nol extract, although it contained high levels of gallic acid,
quercetin, and kaempferol derivatives: this suggests that
these compounds could not be the main responsible for the
radical scavenging properties of the extract [34]. A weakly
DPPH scavenging activity was also reported for the leaves
of Humulus lupulus [46].
Under our experimental condition, the HOP extract also
exhibited antioxidant effect in the crocin bleaching assay
(Figure 7), being the IC50 value about 44-fold higher than
that of Trolox (Table 4). Crocin bleaching represents a com-
mon antioxidant method, which uses crocin as the substrate
and AAPH as a source of free radicals: the antioxidant com-
petes with crocin and interferes with the bleaching of crocin.
This assay is classified among those that involve the transfer
of one hydrogen and is suitable for aqueous systems [47].
On the basis of the Pearson analysis, the crocin bleaching
inhibition by extract resulted significantly correlated with
the scavenger activity of both DPPH and ABTS radicals
(Table 5). Although both DPPH and crocin bleaching
assays are based on the hydrogen transfer for blocking
radicals, the HOP extract resulted most potent against
the crocin-derived radicals respect to DPPH radical. This
difference could be due to the reaction media required
for each assay (an aqueous medium for crocin solubiliza-
tion, while methanol or ethanol for DPPH) [48], in which
certain bioactive compounds can be low soluble and thus
weakly effective. In this context, the aqueous medium
seems to favor the radical scavenging properties of the
HOP extracts, thus suggesting the presence of hydrosolu-
ble bioactive constituents.
The HOP extract was also found able to inhibit the lipid
peroxidation in the ferric thiocyanate assay, already at low
concentrations (Figure 8), as confirmed by the IC50 value
(Table 4). Lipid peroxidation consists of a series of free
radical-mediated chain reaction processes and is associated
with several types of biological damage [48]. The ferric thio-
cyanate method, here used, measures the amount of perox-
ides, which are produced by lipid oxidation during the
initial stages of ROS damage. In this assay, hydroperoxides
are produced from the autoxidization of linoleic acid and
are measured indirectly by the formation of ferric thiocya-
nate complex. According to the Pearson analysis, the inhibi-
tion of lipoperoxidation by HOP extract resulted significantly
correlated with its radical scavenger activity (Table 5), thus
suggesting that blocking the radical species can prevent the
induction of lipid peroxidation. Taking into account that
lipid peroxidation represents a major form of cellular oxida-
tion damage, initiated by hydroxyl free radical through the
extraction of hydrogen atom from unsaturated fatty acids
of membrane phospholipids [49], we can hypothesize that
HOP extract can interfere with the peroxidation of the cell
biomembranes (by direct ROS neutralization or by blocking
their generation) and prevent their structural changes, thus
resulting in cytoprotective effects.
Under our experimental conditions, the extract resulted
also able to reduce the ferric ions, although with a lower
potency (about 140-fold) than the positive control Trolox
Table 4: IC50 values of the HOP extract and the standard antioxidant agent Trolox in the antioxidant assays.
HOP extract Trolox
IC50 (CL) μg/ml
DPPH scavenging activity 574.1 (392.1–840.3) 5.0 (4.4–5.8)
ABTS scavenging activity 311.1 (724.5–1146.2) 2.1 (1.6–2.4)
Inhibition of crocin bleaching 288.6 (270.8–320.4) 6.6 (3.7–11.5)
Lipoperoxidation inhibition 124.1 (91.2–168.7) 3.0 (1.1–7.6)
Fe3+ reducing activity 210.9 (110.5–329.3) 1.5 (1.1–2.0)
Table 5: Pearson correlation coefficient among antioxidant activity assays for the HOP extract.
Pearson’s r (CL; R2)
DPPH scavenger
activity
ABTS scavenger
activity
Crocin bleaching
inhibition
Lipoperoxidation
inhibition
Fe3+ reducing
activity
DPPH scavenger
activity
1 — — — —
ABTS scavenger
activity
0.97∗∗ (0.83–0.99;
0.95)
1 — — —
Crocin bleaching
inhibition
0.96∗∗ (0.53–0.99;
0.93)
0.99∗∗ (0.86–0.99;
0.98)
1 — —
Lipoperoxidation
inhibition
0.96∗ (0.23–0.99;
0.92)
0.99∗∗ (0.81–0.99;
0.99)
0.99∗∗ (0.3–0.99; 0.99) 1 —
Fe3+ reducing activity nsc nsc nsc 0.88∗ (0.3–0.92; 0.78) 1
∗P < 0 05 or ∗∗P < 0 01, statistically significant correlation (two-tailed t-test). nsc: not significantly correlated; CL: confidential limits.
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(Table 4). As estimated by the Pearson analysis, the Fe3+
reducing activity appeared to be related with the
lipoperoxidation inhibition (Table 5). ROS species
production can be also facilitated by elemental species, such
as iron, involved in metal-catalysed oxidation of biological
substrates and in oxygen reactive species generation [48].
Ferric reducing power, based on the electron donating
capacity of the antioxidant, represents a further antioxidant
and cytoprotective mechanism, since reducing species can
be oxidized in place of biological substrates [50]. In this
context, our results showed that the HOP extract contains
reducing species, which can be involved in the inhibition of
lipid peroxidation. This effect should also contribute to
counteract the redox imbalance induced by viral infections,
thus mediating both cytoprotective and antiviral effects.
Accordingly, the Pearson analysis indicated that the
antiviral activity of HOP extract was significantly correlated
with its antioxidant properties, particularly Fe3+ reducing
activity and lipoperoxidation inhibition (Table 6).
Taken together, present results suggest that the HOP
extract is able to interfere both directly and indirectly with
the ROS-mediated cell injury. It is also plausible that HOP
extract might interfere with NOX4 enzyme or with down-
stream pathways that are activated by oxidative stress.
Antioxidant properties of H. lupulus have been widely
ascribed to its phenolic constituents. The most significant
antioxidant activities are displayed by prenylated chalcones
(i.e., xanthohumol) mainly due to their prenyl group [51].
Prenylflavonoids were reported able to chelate bivalent
metals, thereby inhibiting the ROS generation. On the other
hand, the antioxidant properties of different polyphenols,
such as quercetin, chlorogenic acid, syringic acid, benzoic
acid, catechin, and epigallocatechin, have been published
[24, 52]. Therefore, all these compounds can contribute to
the biological activity of the extract.
4. Conclusion
In the present study, we described the antiviral properties of a
hydroalcoholic extract from the female inflorescences of H.
lupulus, focusing on its ability to both directly counteract
the viral replication and viral protein synthesis and indirectly
increase the hosting cell defense by antioxidant mechanisms,
likely due to its phenolic content.
Very limited evidence on the antiviral properties of H.
lupulus and its characteristic constituents is available in liter-
ature. Buckwold et al. [25] found no antiviral effects of hop
crude extracts and its chalcones against the influenza A and
B viral strains.
H. lupulus cones represent an important source of
phenolic compounds, some of which are reported to
produce inhibitory effects against several viral infections
[53–58]. Particularly, among the polyphenols identified in
the HOP extract, rutin and quercetin were reported to
inhibit the influenza infection in animal models, as well as
the viral neuraminidase activities in vitro [59–61] and
syringic acid and gallic acid were found to be potent anti-
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Figure 7: Effect of HOP extract on the AAPH-induced crocin
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Figure 8: Effect of HOP extract on the linoleic acid oxidation (24 h
of incubation) as measured by the ferric thiocyanate method. Data
are mean± SE from two independent experiments, each one
performed in two technical replicates (n = 4).
Table 6: Pearson correlation coefficient between antiviral activity
and antioxidant activity of the HOP extract.
Antiviral activity Pearson’s r (CL; R2)
DPPH scavenger activity nsc
ABTS scavenger activity nsc
Crocin bleaching inhibition 0.99∗∗ (0.53–0.99; 0.98)
Inhibition of lipoperodixation 0.99∗∗ (0.63–0.99; 0.98)
Fe2+ chelating activity 0.99∗∗ (0.88–0.99; 0.99)
∗∗P < 0 01, statistically significant correlation (two-tailed t-test). nsc: not
significantly correlated; CL: confidential limits.
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influenza compounds [62, 63]. This evidence supports our
hypothesis about the possible involvement of the phenolic
constituents in the antiviral properties of the HOP extract.
Particularly, rutin, syringic acid, and gallic acid appear to
be the potential bioactive constituents, although the
contribution of all the phytocomplex cannot be excluded.
Altogether, these compounds can act by both interfering
with the virion life cycle and by reinforcing the defenses of
hosting cells, mainly counteracting the redox imbalance
required for the viral infection establishment.
In conclusion, our results suggest that the HOP extract is
able to exert dual antiviral and cytoprotective effects, which
can be useful in the prevention and treatment of influenza.
Further investigations are encouraged in order to define
the possible application of the HOP extract as an anti-
influenza remedy or in combination with conventional
antiviral drugs.
Data Availability
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Supplementary Materials
Figure S1: high-performance thin-layer chromatography
(HPTLC) of the polyphenolic compounds of the HOP
extract. (a) Visualization at 366nm without derivatization.
(b) Visualization at 366nm after natural product reagent
(NPR) derivatization. (c) Visualization under white light
after NPR and anisaldehyde derivatization. (d) Visualization
at 366nm after anisaldehyde/NPR derivatization. (e) Visuali-
zation at 255 nm. Figure S2: effect of the HOP extract on rep-
lication of different influenza viral strains in A549 cells. (a)
Viral titer measured in supernatants of A549 cells infected
with pH1N1, NWS, or ULSTER strain, following incubation
of the virus with 140μg/ml of HOP extract. (b) Western blot
analysis of viral proteins from samples obtained as described
in (a). Figure S3: effect of the HOP extract (60–140μg/ml)
on the oxidative damage induced by tert-butyl hydroperoxide
(tBOOH; 5μM) in A549 (a) and Caco-2 cells (b). Figure S4:
GSH levels measured in A549 cell lysates treated with tBOOH
or tBOOH and HOP extract (140μg/ml) under pretreatment
(a) and cotreatment plus posttreatment (b) protocols. Figure
S5: morphology of A549 cells treated with tBOOH or tBOOH
and HOP extract (140μg/ml) under the cotreatment plus
posttreatment protocol. (Supplementary Materials)
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